Philips Global Survey Finds Healthcare Leaders to Increase AI Investment Post COVID-19 Pandemic
|
By HospiMedica International staff writers Posted on 10 May 2021 |

Illustration
Investments in artificial intelligence (AI) by healthcare leaders is all set to increase after the COVID-19 pandemic, according to the largest global survey of its kind covering nearly 3,000 healthcare leaders globally.
Royal Philips’ (Amsterdam, the Netherlands) Future Health Index (FHI) 2021 report: ‘A Resilient Future: Healthcare leaders look beyond the crisis’ is based on proprietary research across 14 countries, representing the largest global survey of its kind to analyze the current and future priorities of healthcare leaders worldwide. Feedback from healthcare leaders - including executive officers, financial officers, technology and information officers, operations officers and more - explores the challenges they have faced since the onset of the pandemic, and where their current and future priorities lie, revealing a new vision for the future of healthcare. With a focus on patient-centered healthcare enabled by smart technology, their vision is shaped by a fresh emphasis on partnerships, sustainability and new models of care delivery, both inside and outside the hospital.
While still grappling with the pandemic, 64% of healthcare leaders around the world continue to prioritize telehealth when it comes to digital health technology investments. This number is particularly high in the US (89%). However, in the next three years, only 40% expect to invest heavily in telehealth and AI emerges as a key area for investment (36% today, 74% in three years). Healthcare leaders in emerging economies like Saudi Arabia (98%), India (94%) and Russia (85%) plan to prioritize investments in AI the most in 2024, even more than those in the US. (80%).
Roughly one third (36%) of European healthcare leaders and one quarter (27%) of those in APAC agree that, to be prepared for the future, their hospital or healthcare facility most needs to invest in implementing predictive technologies like AI and machine learning. Notably, in technologically advanced Singapore, the numbers are higher, with nearly two thirds (62%) of healthcare leaders prioritizing an investment in AI post-pandemic. And while lower, Europe and APAC are still above the averages for the Americas (12%) and the Middle East & Africa (6%) when it comes to prioritizing AI in 2024.
“The Future Health Index 2021 report reflects pockets of positivity amid the COVID-19 crisis. Healthcare leaders have seen first-hand how digital health technology can ensure the continued delivery of care in incredibly difficult circumstances,” said Jan Kimpen, Chief Medical Officer, Philips. “Many are now reassessing their technology capabilities as they consider what’s next. While we can’t be sure what the next few years hold, what shines forth from this report is that healthcare leaders are committed to building healthcare systems that are sustainable, adaptable and - above all - resilient.”
Related Links:
Royal Philips
Royal Philips’ (Amsterdam, the Netherlands) Future Health Index (FHI) 2021 report: ‘A Resilient Future: Healthcare leaders look beyond the crisis’ is based on proprietary research across 14 countries, representing the largest global survey of its kind to analyze the current and future priorities of healthcare leaders worldwide. Feedback from healthcare leaders - including executive officers, financial officers, technology and information officers, operations officers and more - explores the challenges they have faced since the onset of the pandemic, and where their current and future priorities lie, revealing a new vision for the future of healthcare. With a focus on patient-centered healthcare enabled by smart technology, their vision is shaped by a fresh emphasis on partnerships, sustainability and new models of care delivery, both inside and outside the hospital.
While still grappling with the pandemic, 64% of healthcare leaders around the world continue to prioritize telehealth when it comes to digital health technology investments. This number is particularly high in the US (89%). However, in the next three years, only 40% expect to invest heavily in telehealth and AI emerges as a key area for investment (36% today, 74% in three years). Healthcare leaders in emerging economies like Saudi Arabia (98%), India (94%) and Russia (85%) plan to prioritize investments in AI the most in 2024, even more than those in the US. (80%).
Roughly one third (36%) of European healthcare leaders and one quarter (27%) of those in APAC agree that, to be prepared for the future, their hospital or healthcare facility most needs to invest in implementing predictive technologies like AI and machine learning. Notably, in technologically advanced Singapore, the numbers are higher, with nearly two thirds (62%) of healthcare leaders prioritizing an investment in AI post-pandemic. And while lower, Europe and APAC are still above the averages for the Americas (12%) and the Middle East & Africa (6%) when it comes to prioritizing AI in 2024.
“The Future Health Index 2021 report reflects pockets of positivity amid the COVID-19 crisis. Healthcare leaders have seen first-hand how digital health technology can ensure the continued delivery of care in incredibly difficult circumstances,” said Jan Kimpen, Chief Medical Officer, Philips. “Many are now reassessing their technology capabilities as they consider what’s next. While we can’t be sure what the next few years hold, what shines forth from this report is that healthcare leaders are committed to building healthcare systems that are sustainable, adaptable and - above all - resilient.”
Related Links:
Royal Philips
Latest COVID-19 News
- Low-Cost System Detects SARS-CoV-2 Virus in Hospital Air Using High-Tech Bubbles
- World's First Inhalable COVID-19 Vaccine Approved in China
- COVID-19 Vaccine Patch Fights SARS-CoV-2 Variants Better than Needles
- Blood Viscosity Testing Can Predict Risk of Death in Hospitalized COVID-19 Patients
- ‘Covid Computer’ Uses AI to Detect COVID-19 from Chest CT Scans
- MRI Lung-Imaging Technique Shows Cause of Long-COVID Symptoms
- Chest CT Scans of COVID-19 Patients Could Help Distinguish Between SARS-CoV-2 Variants
- Specialized MRI Detects Lung Abnormalities in Non-Hospitalized Long COVID Patients
- AI Algorithm Identifies Hospitalized Patients at Highest Risk of Dying From COVID-19
- Sweat Sensor Detects Key Biomarkers That Provide Early Warning of COVID-19 and Flu
- Study Assesses Impact of COVID-19 on Ventilation/Perfusion Scintigraphy
- CT Imaging Study Finds Vaccination Reduces Risk of COVID-19 Associated Pulmonary Embolism
- Third Day in Hospital a ‘Tipping Point’ in Severity of COVID-19 Pneumonia
- Longer Interval Between COVID-19 Vaccines Generates Up to Nine Times as Many Antibodies
- AI Model for Monitoring COVID-19 Predicts Mortality Within First 30 Days of Admission
- AI Predicts COVID Prognosis at Near-Expert Level Based Off CT Scans
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read moreCritical Care
view channel
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read more
First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
Pulmonary hypertension is a progressive, life‑threatening disease that is frequently missed early because symptoms such as dyspnea are nonspecific and diagnostic delays can exceed two years.... Read moreSurgical Techniques
view channel
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel








